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Magnetoencephalography of cognitive responses
A sensitive method for the detection of age-related changes
Magnetoencephalography (MEG) is a novel,state-of-
the-art technique used in clinical neurophysiology,
which promises better understanding of brain
(dys)function.The “whole-head” MEG sensor-array
enables a noninvasive visualization of the intracellular
currents involved in transmission and process-
ing of information in the working brain,on a
millisecond timescale, taking into account
all (superficial and deep) parts of the
CNS simultaneously. 3D reconstruction
algorithms are used to attribute sources
to anatomically defined structures and
cortical subdivisions. MEG recording
during the performance of a simple
decision-making task using a continu-
ous Go-NoGo paradigm (=P300)
enables the evaluation of the mechanisms
of attentional and intellectual capabilities.
Many psychiatric disorders are related
to a state of confusion or disturbances
of thought.This poster presents a brief
report on fundamental and clinical
research into cognitive decline during
(normal) aging, carried out with our
innovative MEG equipment.
In healthy subjects asked to discriminate high-pitched
target tones among standard tones during an oddball
detection task, when attention is correctly directed,
a particular transient electrical potential is observed,
called P300,
1 with maximal amplitudes around 
the vertex. The underlying generators are
thought to be located in the medial tempo-
ral lobe regions.We recently demonstrat-
ed that MEG signals yield a more com-
plete image of the complex neuronal
interactions involved in this type of cog-
nitive response,showing a large positive
pole over the left precentral and frontal
brain regions (Figure 1) and a mirror-
image pattern in the right hemisphere
(not shown).
2 We are currently in the
process of localizing the sources in a real-
istic head model.
Researchers at our Institute are running programs to explore pathophysiological changes in schizo-
phrenics, abstinent alcoholics, and Alzheimer patients, in comparison with normal aging in control sub-
jects.This is achieved by plotting amplitude and latency parameters for individual subjects as a function
of age (Figure 2). Significant decline is found in subjects at the far ends of our age-range. Regression
analysis shows a loss of signal of about 15% with a slowing of 10 to up to 20 ms with every decade of life.
Preliminary findings indicate that MEG recordings are able to evidence age-related changes, as do elec-
trical responses, and that these are already clearly visible before the age of 50 years.The slope of change
in signal peak parameters is steeper than described in the literature for an even wider range of ages and
pathophysiological situations.
9
Figure 1. Top: 3D mapping of positive pole of MEG
response to target tones. Bottom: averaged tracings
in Broca’s area for 2 age groups (young [<25 y] ––;
mid-age [34-47 y],      ). Note the sustained positive
wave >300 ms (horizontal scale 100 ms/division). 
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Intermezzo 1
In the aging brain, a general attenuation of the P300 response with a slowing of the time to reach the peak in drug-
free volunteers (Figures 1 and 2C, D) is reported.
3 In young healthy volunteers, this response, characterized by its
peak amplitude and peak latency, is known to be at least partly under cholinergic control
4,5 and can be enhanced
by psychotropic drugs.
6 In the elderly, nootropic drugs are able to achieve a significant, restoration of P300.
7,8 The
proven relationship between psychopharmacology, conscious attention, evoked (cognitive) responses and brain
anatomy is a cornerstone concept in biological psychiatry research.In conclusion:
MEG imaging provides a
novel means of studying the
neuronal events involved in
the recruitment of attention-
al resources,and could her-
ald new discoveries in the
field of integrative brain
functions.
Figure 2. A. Scattergram of ampli-
tude (ampl) for target-specific MEG
response in Broca's area; B. Mean
amplitude of electrical response
(P300, Cz electrode) in young (  )
and aged (  ) healthy subjects; 
C. Scattergram of MEG response
latency; D. mean latency for P300.
Intermezzo 2
Perspectives: The sensitivity of MEG in identifying modifications in normal adults makes it a promising
diagnostic tool in the early identification of various forms of dementia.
10 Studies are currently being carried
out in patients with dementia and related mood disorders, in collaboration with the World Health Organi-
zation (WHO),in order to validate the technique.
One of the advantages of MEG as applied to sensory physiology is that straightforward activation maps (eg, audi-
tory response, see Figure 3) can be recorded. Source localization through MEG has yielded revolutionary results
for the evaluation 
of impaired hearing,
stroke, or epilepsy,
11
and is even able to
demonstrate disturbed
patterns in schizo-
phrenic patients.
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Figure 3. A. Auditory MEG
response;  B. Topographic
mapping; C. Source localiza-
tion (red arrow) using a spher-
ical model. 
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